QUANTITATIVE MODELING AND ANALYTICS

Our Quantitative Modeling and Analytics services are aimed at helping clients make objective, sound decisions requiring tasks such as valuing their IP within key markets or globally…or evaluating strategic options such as a candidate technology/compound to in-or out-license. We provide assessment that can help establish a strong starting point for in-house decision-making or deal negotiations. Our approach relies on the development of models tailored to each client engagement, allowing for robust sensitivity analyses and extensive utility beyond the initial decision/evaluation.

Additionally, clients that wish to highlight the potential impact of a compound or technology prior to entering new markets such as China. An external assessment of anticipated cost savings and health benefits associated with a novel product versus the current standard of care within the industry can help position it for a successful market launch. Cost-effectiveness or cost-utility analyses of biochemical compounds are increasingly becoming the gold standard for formulary listing and our assistance can help you reach this goal. Using approaches that factor parameters such as cost savings, added quality of life/life years (QALY/LY), our Markov and decision tree models objectively evaluate whether or not your IP/technology is likely to succeed among the current standard of care.

Our ability to access and employ data from the Chinese market provides you with critical information for evaluating the value of your IP/technology and the likelihood that it will successfully reach its target market and yield strong return-on-investment.

Services that fall under this category include:

• Technology and IP Valuation Models
• Project Feasibility Assessment
• Decision Analysis